Gender-Specific Differences in the Kinetics of Nonfasting TRL, IDL, and LDL Apolipoprotein B-100 in Men and Premenopausal Women
暂无分享,去创建一个
[1] N. Unwin,et al. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .
[2] B. S. Mohammed,et al. Women produce fewer but triglyceride-richer very low-density lipoproteins than men. , 2007, The Journal of clinical endocrinology and metabolism.
[3] R. Ramakrishnan,et al. Studying Apolipoprotein Turnover with Stable Isotope Tracers: Correct Analysis Is by Modeling Enrichments Constant Tracee Flux Implies That Protein Amount Changes with Time , 2022 .
[4] P. Wolf,et al. Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.
[5] D. Demello. Arteries and Veins , 2006, Encyclopedia of Respiratory Medicine.
[6] C. Tsunehara,et al. Sex differences in lipoprotein metabolism and dietary response: Basis in hormonal differences and implications for cardiovascular disease , 2006, Current atherosclerosis reports.
[7] A. Lichtenstein,et al. TRL, IDL, and LDL Apolipoprotein B-100 and HDL Apolipoprotein A-I Kinetics as a Function of Age and Menopausal Status , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[8] M. Costanza,et al. Relative contributions of genes, environment, and interactions to blood lipid concentrations in a general adult population. , 2005, American journal of epidemiology.
[9] B. Scherstén,et al. Serum lipids and lipoproteins in relation to endogenous and exogenous female sex steroids and age. The Women's Health in the Lund Area (WHILA) study. , 2004, Maturitas.
[10] R. Eckel,et al. Dietary Hydrogenated Fat Increases High-Density Lipoprotein apoA-I Catabolism and Decreases Low-Density Lipoprotein apoB-100 Catabolism in Hypercholesterolemic Women , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[11] Christine M. Williams,et al. Lipid metabolism in women , 2004, Proceedings of the Nutrition Society.
[12] L. Mosca,et al. Epidemiology of coronary heart disease in women. , 2004, Progress in cardiovascular diseases.
[13] J. Hsia,et al. Usefulness of prior hysterectomy as an independent predictor of Framingham risk score (The Women's Health Initiative). , 2003, The American journal of cardiology.
[14] S. Deeb,et al. Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. , 2003, Journal of lipid research.
[15] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[16] A. Lichtenstein,et al. Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors. , 2002, Atherosclerosis.
[17] B. Landgren,et al. Lipoproteins and BMI: a comparison between women during transition to menopause and regularly menstruating healthy women. , 2002, Maturitas.
[18] W. Kannel. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. , 2002, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.
[19] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[20] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[21] S. Fortmann,et al. Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford Five City Project. , 2000, Preventive medicine.
[22] G. Watts,et al. Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies. , 2000, Metabolism: clinical and experimental.
[23] C. Bouchard,et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[24] A. Lichtenstein,et al. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[25] A. Lichtenstein,et al. Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins. , 1999, Journal of lipid research.
[26] A. Lichtenstein,et al. Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[27] E. Vartiainen,et al. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. , 1999, Circulation.
[28] L. Kuller,et al. Smoking cessation, weight gain, and changes in cardiovascular risk factors during menopause: the Healthy Women Study. , 1998, American journal of public health.
[29] F. Sacks,et al. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. , 1997, The Journal of clinical endocrinology and metabolism.
[30] J. Staessen,et al. Conventional and ambulatory blood pressure and menopause in a prospective population study , 1997, Journal of Human Hypertension.
[31] J. Peters,et al. Assessment of the nutritional effects of olestra, a nonabsorbed fat replacement: summary. , 1997, The Journal of nutrition.
[32] E. Barrett-Connor,et al. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. , 1997, Circulation.
[33] J. Ordovás,et al. Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[34] E. Poehlman,et al. Menopause‐associated changes in plasma lipids, insulin‐like growth factor I and blood pressure: a longitudinal study , 1997, European journal of clinical investigation.
[35] P. Wilson,et al. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. , 1996, Journal of lipid research.
[36] E. Casiglia,et al. Lack of influence of menopause on blood pressure and cardiovascular risk profile: a 16-year longitudinal study concerning a cohort of 568 women , 1996, Journal of hypertension.
[37] P. Amouyel,et al. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. , 1995, Atherosclerosis.
[38] A. Lichtenstein,et al. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men. , 1995, Journal of lipid research.
[39] D. H. Williams,et al. Natural menopause and cardiovascular disease risk factors. The Poland and US Collaborative Study on Cardiovascular Disease Epidemiology. , 1994, Annals of epidemiology.
[40] K. Anderson,et al. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. , 1994, Journal of gerontology.
[41] F. Sacks,et al. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. , 1994, Journal of lipid research.
[42] P. Wilson,et al. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. , 1994, Journal of lipid research.
[43] I. Godsland,et al. Influence of age and menopause on serum lipids and lipoproteins in healthy women. , 1993, Atherosclerosis.
[44] G. Schonfeld,et al. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes. , 1991, Journal of lipid research.
[45] J. Ordovás,et al. Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein A-I and B-100 kinetics. , 1990, Journal of lipid research.
[46] P. Wilson,et al. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. , 1988, The Journal of clinical endocrinology and metabolism.
[47] I. Godsland,et al. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. , 1987, American heart journal.
[48] P. Wilson,et al. Enzyme-linked Immunosorbent Assay for Human Plasma Apolipoprotein B , 2022 .
[49] E. Schaefer,et al. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. , 1987, Clinica chimica acta; international journal of clinical chemistry.
[50] A. Whittemore,et al. Menopause and the risk of coronary heart disease in women. , 1987, The New England journal of medicine.
[51] H. Brewer,et al. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. , 1983, The Journal of clinical endocrinology and metabolism.
[52] Arthur J. Moss,et al. The Heart, Arteries, and Veins , 1983 .
[53] J. Albers,et al. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.
[54] R. Havel,et al. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.